The report “China Precision Medicine Market, By Applied Sciences (Genomics and Pharmacogenomics), By Digital Health and Information Technology (CDSS, Big Data Analytics, IT Infrastructure, Genome Informatics, In-Silicon Informatics, and Mobile Health), and By Application (Oncology, Infectious Diseases, Neurology/Psychiatry, Lifestyle & Endocrinology, Cardiology, and Gastroenterology) – Trends, Analysis and Forecast till 2030”. China Precision Medicine is projected to grow from US$ 5.0 billion in 2018 to US$ 18.3 billion in 2029 with a CAGR of 12.9%. Shifting the significance in medicine from reaction to prevention is the major factor driving the growth of the China precision medicine market. Also, increasing government initiatives for the incorporation of precision medicine in China is boosting the growth of the target market. Increasing cases of breast cancer in Chinese’s women are also expected to drive the growth of the target market over the forecast period. According to data published by Science Translational Medicine Journal in 2016, it is estimated that 268,600 new breast cancer cases were diagnosed in Chinese women in 2015.
- In November 2019, Thermo Fisher Scientific has launched its Ion Torrent Genexus System, the first fully integrated, next-generation sequencing (NGS) platform featuring an automated specimen-to-report workflow that sends results economically in a single day. The company also introduced its Oncomine Precision Assay, an innovative pan-cancer panel for the Genexus platform. It offers comprehensive genomic profiling from formalin-fixed, paraffin-embedded (FFPE) tissue and liquid biopsy samples with a single assay.
Key Market Insights from the report:
The China Precision Medicine market accounted for US$ 357.32 million in 2019 and is projected to register a moderate CAGR of 28.17% over the forecast period. The market report has been segmented based on the property type.
- Based on applied sciences, genomics segment in China is dominating the market due to its leading way in data collection and analysis tools to understand human genetics and biology. The Beijing Genome Institute is the world’s largest repository and sequencer of genetic material – the DNA code that makes each unique.
- Based on digital health and information technology, the China precision medicine market is bifurcated into CDSS, big data analytics, IT infrastructure, genome informatics, in-silicon informatics, and mobile health.
- Based on application, the target market is segmented into oncology, infectious diseases, neurology/psychiatry, lifestyle & endocrinology, cardiology, and gastroenterology.
Browse 60 market data tables* and 35 figures* through 140 slides and in-depth TOC on “China Precision Medicine Market”, By Applied Sciences (Genomics and Pharmacogenomics), By Digital Health and Information Technology (CDSS, Big Data Analytics, IT Infrastructure, Genome Informatics, In-Silicon Informatics, and Mobile Health), and By Application (Oncology, Infectious Diseases, Neurology/Psychiatry, Lifestyle & Endocrinology, Cardiology, and Gastroenterology) – Trends, Analysis and Forecast till 2030
To know the upcoming trends and insights prevalent in this market, click the link below:
The prominent player operating in the Australia Plastic Packaging market includes Thermo Fisher Scientific Inc., BGI Genomics Co., Ltd., F. Hoffmann-La Roche Ltd., Illumina, Inc., Shanghai Fosun Pharmaceutical Group, WuXi AppTec, Berry Genomics Co., Ltd., Agilent Technologies, Inc., and PerkinElmer Inc.
About Prophecy Market Insights
Prophecy Market Insights is specialized market research, analytics, marketing/business strategy, and solutions Development Company that offers strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high-value opportunities in the target business area. We also help our clients to address business challenges and provide the best possible solutions to overcome them and transform their business.
Prophecy Market Insights